Express Scripts (Evernorth) reports that GLP-1 drugs became the fastest-growing pharmacy benefit expenditure category in U.S
Differences in the study population or trial design could account for these differences
With lunch: calcium (500 to 600mg for bone protection during rapid weight loss)
Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
What the TRIUMPH 4 Phase 3 Data Actually Shows The phase 2 data that first made headlines reported approximately 24 percent body weight loss at 48 weeks
This will promote overall well-being and support the bodys natural processes
